Boston Scientific has agreed to buy thrombectomy company Penumbra for about $15 billion in cash and stock in a deal that bolsters its cardiovascular portfolio.
Source link
Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock
Date:
More like thisRelated
Albuquerque releases new bike map showing all bicycle routes across the city
ALBUQUERQUE, N.M. (KRQE) – After miles and miles of...
Hurricanes-Golden Knights Game 3 takeaways, grades, questions
Nothing. Nothing. Nothing. Then chaos. This is the easiest...
Goodwill bin find in Oklahoma City leads to diploma return
An Oklahoma TikToker who found a 1954 high school...